Kiewe P - Search Results

1

Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.

Kiewe P, Hasmüller S, Kahlert S, Heinrigs M, Rack B, Marmé A, Korfel A, Jäger M, Lindhofer H, Sommer H, Thiel E, Untch M. Kiewe P, et al. Clin Cancer Res. 2006 May 15;12(10):3085-91. doi: 10.1158/1078-0432.CCR-05-2436. Clin Cancer Res. 2006. PMID: 16707606 Clinical Trial.

2

Ertumaxomab: a trifunctional antibody for breast cancer treatment.

Kiewe P, Thiel E. Kiewe P, et al. Expert Opin Investig Drugs. 2008 Oct;17(10):1553-8. doi: 10.1517/13543784.17.10.1553. Expert Opin Investig Drugs. 2008. PMID: 18808314 Review.

3

Reversible ageusia after chemotherapy with pegylated liposomal doxorubicin.

Kiewe P, Jovanovic S, Thiel E, Korfel A. Kiewe P, et al. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1212-4. doi: 10.1345/aph.1E116. Epub 2004 May 25. Ann Pharmacother. 2004. PMID: 15161947

4

Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.

Jahnke K, Hummel M, Korfel A, Burmeister T, Kiewe P, Klasen HA, Müller HH, Stein H, Thiel E. Jahnke K, et al. Among authors: kiewe p. J Clin Oncol. 2006 Oct 10;24(29):4754-7. doi: 10.1200/JCO.2006.06.7165. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966685

5

High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.

Kiewe P, Loddenkemper C, Anagnostopoulos I, Reinwald M, Thiel E, Korfel A. Kiewe P, et al. Neuro Oncol. 2007 Apr;9(2):96-102. doi: 10.1215/15228517-2006-037. Epub 2007 Feb 14. Neuro Oncol. 2007. PMID: 17301290 Free PMC article.

6

Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Kiewe P, et al. Cancer. 2008 Apr 15;112(8):1812-20. doi: 10.1002/cncr.23377. Cancer. 2008. PMID: 18318432 Free article. Clinical Trial.

7

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E. Fischer L, et al. Among authors: kiewe p. Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5. Ann Hematol. 2009. PMID: 18679681

8

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Maza S, Kiewe P, Munz DL, Korfel A, Hamm B, Jahnke K, Thiel E. Maza S, et al. Among authors: kiewe p. Neuro Oncol. 2009 Aug;11(4):423-9. doi: 10.1215/15228517-2008-108. Epub 2008 Dec 5. Neuro Oncol. 2009. PMID: 19060176 Free PMC article. Clinical Trial.

9

Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study.

Sebastian M, Kiewe P, Schuette W, Brust D, Peschel C, Schneller F, Rühle KH, Nilius G, Ewert R, Lodziewski S, Passlick B, Sienel W, Wiewrodt R, Jäger M, Lindhofer H, Friccius-Quecke H, Schmittel A. Sebastian M, et al. Among authors: kiewe p. J Immunother. 2009 Feb-Mar;32(2):195-202. doi: 10.1097/CJI.0b013e318195b5bb. J Immunother. 2009. PMID: 19238019 Clinical Trial.

10

CXCL13 and CXCL12 in central nervous system lymphoma patients.

Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD, Cakiroglu H, Widmann T, Thiel E. Fischer L, et al. Among authors: kiewe p. Clin Cancer Res. 2009 Oct 1;15(19):5968-73. doi: 10.1158/1078-0432.CCR-09-0108. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters